RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Bridget Kelly

Bridget Kelly

Health Communication Research Scientist


PhD, Health Communication, Annenberg School for Communication, University of Pennsylvania
MPH, Health Promotion/Disease Prevention, Columbia University
BA, Journalism, Ithaca College

Bridget Kelly, program manager for RTI’s Science in the Public Sphere program, studies topics in public health and health communication using qualitative and quantitative research methods. She has conducted research for clients including the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, and the National Cancer Institute.

Several of Dr. Kelly’s current projects focus on direct-to-consumer prescription drug advertising, and effects on perceptions of prescription drug risks and benefits. Dr. Kelly also studies communication during infectious disease outbreaks and has worked on projects involving H1N1 influenza information; Ebola perceptions; and pandemic flu preparedness. Before joining RTI in 2007, Dr. Kelly worked in the Center for Excellence in Cancer Communication Research at the University of Pennsylvania. She serves as a reviewer for a variety of public health and communication journals and is on the editorial board for Health Communication.

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics